Zenabis Global Inc. Completes an At-the-Market Equity Offering Program

February 09, 2021

Zenabis Global Inc. (“Zenabis”), a licensed cultivator of medical and recreational cannabis, established an at-the-market equity program (the “ATM Program”) that allows Zenabis to issue up to $15,000,000 of common shares in the capital of Zenabis from treasury to the public from time to time, at Zenabis’ discretion. The ATM Program was conducted by Echelon Wealth Partners Inc. (the “Agent”).

Wildeboer Dellelce LLP acted for the Agent in connection with the Offering with a team comprised of Jeff Hergott, Joel Fraser, and Mark Coghlan (corporate/securities), and Katy Pitch and Marija Tasevska (Tax).